Caprock Group, Inc. Vaxart, Inc. Transaction History
Caprock Group, Inc.
- $3.21 Billion
- Q1 2025
A detailed history of Caprock Group, Inc. transactions in Vaxart, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 23,000 shares of VXRT stock, worth $9,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,000
Previous 23,000
-0.0%
Holding current value
$9,200
Previous $15,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VXRT
# of Institutions
102Shares Held
27.6MCall Options Held
14.3KPut Options Held
55.2K-
Vanguard Group Inc Valley Forge, PA10.4MShares$4.15 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY5.58MShares$2.23 Million0.86% of portfolio
-
Geode Capital Management, LLC Boston, MA2.66MShares$1.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$709,7380.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny956KShares$382,3460.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $50.6M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...